The French Paradox is a term derived from the observation of a decreased incidence of IHD despite a high intake of saturated fat. 8 This is linked to France and led scientists to attribute this phenomenon to the high consumption of wine. 8 The French Paradox started extensive research into wine and led to the identification of many compounds, namely polyphenols, that are thought to be the basis of wine's apparent cardioprotective potential. Red wine, among other constituents, is also included in the Mediterranean diet, and this diet has been labeled as beneficial by scientific advisory committees. 9 Although excessive or binge drinking of alcoholic beverages is regarded to be detrimental to cardiovascular and general health, light-to-moderate intake of regular amounts is recommended in the literature. 10 Adverse effects of acute and chronic alcohol consumption are dependent on the doses of intake; however, differing opinions exist regarding red wine's potential as a therapeutic agent, regardless of the pattern of drinking. 11 From a public health perspective, alcohol consumption is regarded as a risk factor for chronic diseases, and globally it contributes to an increase in disease burden. 12 Although these detrimental risks are present and may outweigh the benefits of alcohol consumption, wine and alcohol will continue to be ever-present in our society.
With a popular drink like wine surrounded by such scientific intrigue, it is desirable to provide a comprehensive account, from a cardiovascular point of view, of its anatomy, mechanisms of actions, and risks and benefits of consumption. Most reviews and meta-analyses to date have focused on the individual characteristics of wine, but a much more inclusive review of the literature on wine and its comparisons with other alcoholic beverages is needed. This review aims to investigate wine and its cardioprotective potential, highlight the importance of individual components of wine and their interactions with the cardiovascular system at large, and present upto-date epidemiological and experimental evidence of wine's impact on chronic cardiovascular diseases. We also address the debate around the light-to-moderate intake of consumption, variable definitions of drinking, and current recommendations for consumption.
DEFINITIONS OF CONSUMPTION What Constitutes a Standard Drink?
Alcoholic intake, if not monitored, can contribute to various adverse conditions that affect day-to-day life. 13 Hence, governments and international institutions have defined a unit called a "standard drink." 14 Epidemiological and experimental studies take advantage of this metric to quantify consumption and assess population risk. Therefore, a standard drink size has become an important, but often publicly misunderstood metric, for population-based studies assessing phenomena related to the intake of alcohol. Quite apparent from the literature is the definition of a standard drink, which varies across country borders and across the scientific literature. 15 A standard drink, or a unit of alcohol in the United Kingdom, is a national concept that is expressed in amounts of pure ethanol. 16 To the general public, it is presented in amounts of beer, wine, or spirits, because they are the most commonly consumed beverages. 16 The units of alcohol in a beverage can vary depending on the source, but most common ones include standard drink, grams, milliliters, ounces, and alcoholic concentration by volume. 17 The guidelines from the World Health Organization (WHO) on standard drink assume 1 standard drink to be 10 g of pure ethanol, with recommendations of not exceeding 2 standard drinks per day, with at least 2 nondrinking days during the week. 18 This definition is not widely adopted across country borders and carries great country-to-country variation. Kalinowski and Humphreys 14 systematically gathered international guidelines on standard drink definitions. Their methods of analysis and most important findings are summarized in Table 1 . They identified 75 governments that did not adopt such a definition. Their analysis included 37 countries that did adopt the WHO standard drink measure but cited large variability between countries, ranging from 8 to 20 g. The authors further reported the 10-g WHO guideline to be the modal definition between countries, with variations ranging from 10 g/d to 56 g/d for low-risk alcohol consumption. The standard drink is defined in terms of pure ethanol. Red wine, beer, and spirits are all composed of some percentage of pure ethanol. The WHO guidelines present a guide on calculating the alcoholic content of a beverage. 18 The method of calculation, variables, and values are presented in Table 2 . The alcoholic content within a drink depends on 2 variables: size of beverage and percent strength of pure ethanol. 18 These variables vary across countries, cultures, and even vendors, but this guideline presents the most common scenario as a tool for drinkers to calculate the amount of pure ethanol in a drink.
A quantitative measure of a standard drink is essential; however, given the mathematical nature, the general public has difficulty comprehending it and would rather prefer a more qualitative, day-to-day metric to regulate their consumption. The WHO guidelines define a standard drink in terms of glasses of wine, beer, liquor, and shots of spirits (Table 3) . They claim that these amounts roughly equal 1 standard drink.
Light, Moderate, and Excessive Consumption
Voskoboinik and coauthors 19 define light alcohol consumption as <7 standard drinks (std) per week, moderate as 7-21 std/wk, and excessive as >21 std/wk. This translates to <1 std/d for light consumption, 1-3 std/d for moderate, and >3 std/d for excessive consumption, where 1 standard drink is defined as 12 g of pure ethanol.
IMPORTANCE OF WINE AS A BIOLOGICAL BEVERAGE
The molecular properties of wine and their interactions with the human body were extensively researched after a negative correlation for IHD was reported with alcohol consumption. Since then, researchers have focused on pinpointing how this beverage imparted cardioprotection against chronic cardiovascular diseases. After fermentation, wine still possesses a mixture of compounds known as polyphenols that, besides ethanol, have emerged as key players in explaining red wine's antioxidant, anti-inflammatory, and cytoprotective properties. 20 
Why Red Wine? The Hypothesis
St Leger and colleagues 3 reported a negative correlation between alcohol consumption and IHD deaths, and attributed this observation predominantly to wine. Renaud and de Lorgeril 8 subsequently described what they called the French Paradox, referring to the indirect observation that the French population consumed red wine with their diet, which was mostly high in saturated fat, so this correlation between wine and cardiovascular mortality was attributed to the consumption of red wine. 21 Since then, numerous studies have come out in favor of wine and alcohol conferring cardiovascular benefits, but with one important caveat: most of these investigations, although involving large sample sizes with cross-cultural and geographical comparisons, were epidemiological. Scientists have thus questioned these results, but intrigue still surrounds the community. Several explanations for the French Paradox have been postulated, 21 with epidemiologists presenting strong correlations in favor of wine (both white and red), with other scientific literature criticizing these observations.
Red Wine Composition
Wine is an alcoholic beverage of complex composition that is obtained through the fermentation of grape must, and thus the quality and variety of grapes used in the vinification process have an impact on the composition of wine. 22 Red wine is composed of >500 compounds, with the most important constituents being water, alcohol (ethanol), and polyphenols. 23 They can be divided into 2 primary groups: the flavonoids and nonflavonoids. The general composition of wine can be viewed in Figure 1 . Flavonoids have been known to provide taste and color to wine while being important for health, while resveratrol (nonflavonoid) is debated to contribute to the potential bioactive properties of wine. Polyphenols amount to only a fraction of wine's total content, but are of particular interest in cardiology for their potential biological and cardioprotective properties.
Red Wine Versus White Wine
Red wine is known to be 10-fold higher in polyphenolic content than white wine, and this variability arises because of red wine's grape must fermentation. 22 This is why white wine is given much less importance than red wine in the literature. In addition, apart from the varying sugar content, polyphenols are the only major component different between red and white wines. There are few studies directly comparing the effects of the 2 drinks; therefore, conclusive evidence regarding the comparison of the 2 wines is poor. Because the polyphenolic ratio in red and white wines differs significantly, white wines' protective mechanisms may be different from red wines'. Bertelli 24 postulates that relatively unknown active compounds identified in white wines, namely tyrosols, caffeic acid, and shikimic acids, might explain the biological basis of white wine's cardioprotective effects.
BIOACTIVE COMPONENTS OF RED WINE

Bioavailability of Polyphenols
The biological properties of polyphenols are only utilizable if they are bioavailable, which is dictated primarily by their chemical structure. Most polyphenols cannot be absorbed in their native form and are chemically modified after ingestion. Post-wine consumption, polyphenols are structurally modified and metabolized fairly quickly; thus, a component of the biological activity from wine is derived from metabolized polyphenols. 25 The bioavailability of wine polyphenols is low; however, there is consistent evidence that bioavailable concentrations after acute and chronic consumption of wine are able to exert beneficial biological effects in vivo. 24 
Flavonoids
Flavonoids are plant-based antioxidants that are included in the family of polyphenols. They are found primarily in vegetables, fruits, and beverages such as tea and wine. 26 Flavonoids can be synthesized only by plants and have been investigated for their protective abilities against chronic cardiac diseases ( Figure 2 ). In the previous few decades, flavonoids have received much attention after epidemiological investigations specifically discovered that dietary flavonoids were inversely associated with IHD mortality. 27 Flavonoids from red wine have been credited to inhibit low-den- sity lipoprotein (LDL) oxidation 28 and prevent endothelial dysfunction, 29 which is postulated to increase atherosclerosis development. 30 Hence, flavonoids have antiatherosclerotic properties that are particularly apparent when wine is studied devoid of ethanol, as dealcoholized wine (see Dealcoholized Red Wine: Cardioprotection of Wine Polyphenols Beyond Ethanol). Of the flavonoids, quercetin is known to be a potent antioxidant because it has been shown to have a negative correlation with cardiovascular mortality. 29 In a dietary investigation of >1000 participants, high quercetin intakes were associated with lower IHD mortality (relative risk 
Quercetin
Quercetin, a plant polyphenol from the flavonoid group, has amassed much scientific intrigue. It is an important dietary flavonoid that is prominent in red wine and the Mediterranean diet. 32 Of the flavonoid group, it is the most abundant dietary flavonoid that has been investigated for its antihypertensive, anti-inflammatory, acute platelet thrombogenesis, and protective capabilities against IHDs. Quercetin is found as a conjugated derivative in plasma, and those metabolites subsequently exert physiological effects. 34 Quercetin is known to be an effective free radical scavenger that prevents LDL oxidation in humans. 35 It causes endothelium-dependent vasodilation of vascular smooth muscles and inhibits platelet aggregation, which can subsequently contribute to atherosclerosis. 29 In apolipoprotein E gene-deficient mice, Loke and colleagues 36 studied quercetin and other dietary flavonoids' capabilities to reduce atherosclerotic lesions. This group demonstrated that quercetin attenuated lesions by inhibiting inflammation, improving nitric oxide (NO) bioavailability, and inducing heme oxygenase-1, which all seemed to have been protective. In human subjects, however, contradictory results have come to light, showing that dietary quercetin did not change biomarkers of inflammation. 37 To elucidate causation, further dose-response, randomized, and placebo-controlled studies are needed.
In dogs with experimental myocardial infarction, quercetin intervention led to an improvement in left ventricular contractile function. 38 Similarly, quercetin has further been documented to protect the myocardial tissue against reperfusion injury and global ischemia. 
Resveratrol
Resveratrol is a nonflavonoid stilbene derivative produced by plants that is prominently present in red wine and grapes. 40 Resveratrol from red wine is postulated to be an important contributor in explaining the French Paradox. The increased publicity of resveratrol's bioactive potential and treatment of chronic disorders such as cardiovascular diseases and cancer has engaged public interest in resveratrol supplements. 41 A number of preclinical and clinical studies have demonstrated a very low oral bioavailability for resveratrol 42 ; however, Goldberg and coworkers 43 demonstrated that resveratrol and other polyphenols reached peak concentrations 30 minutes postprandial, with the absorption of transresveratrol being 20-fold more efficient than the flavonoid catechin. 44 However, broadly speaking for all polyphenols, the bioavailability is enough to exert antioxidant effects. A wealth of data has been collected on resveratrol and its effects on hypertension, atherosclerosis, stroke, myocardial infarction, and heart failure. 45 In general, beneficial effects of the administration of resveratrol as a supplement have been reported for the aforementioned diseases and may be one of the reasons why this compound is being heavily advertised as a cardioprotective supplement.
PUTATIVE MECHANISMS OF ACTION
According to reports, the exact mechanisms of action that underlie cardioprotection for red wine have not yet been causally interpreted; however, in vitro, in vivo, and human epidemiological studies have shown cardiovascular benefits of drinking red wine, and have postulated interesting explanations for cardioprotection. A summary of the biological events and triggering chemicals is presented in Figure 3 .
Protective Mechanisms: Red Wine Polyphenols and Ethanol
Red wine polyphenols reduce platelet aggregation 46 and improve fibrinolysis. 47 The endothelium controls NO release, which subsequently regulates vascular tone, relaxes vascular smooth muscle cells, and inhibits platelet aggregation. 48 Moderate wine consumption increases NO production, 49 which induces vasodilation. 29 Endothelial dysfunction reduces NO bioavailability that is associated with cardiovascular diseases including atherosclerosis, thrombosis, and hypertension. 48 In regard to hypertension, alcohol consumption in moderation is linked to a reduction in systolic and diastolic blood pressure. 50 Polyphenols are strong antioxidants that improve the lipid profile by reducing the susceptibility of LDL to oxidation. 28 Conversely, the intake of red wine increases blood high-density lipoprotein (HDL) levels and triglycerides. 51 Alcohol intake at regular intervals is observed to be beneficial for diabetes mellitus. Light-to-moderate consumption enhances insulin sensitivity by increasing insulin-mediated glucose uptake. 54 Increased insulin sensitivity is proposed to be associated with greater HDL cholesterol and apolipoprotein AI levels 55 and possibly contributes to a decreased incidence of IHD.
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Pathophysiological Mechanisms: Alcohol and Atrial Fibrillation
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. 57 Consumption of alcohol may trigger AF, and sustained consumption may cause atrial electric remodeling. 19 Voskoboinik and coworkers 19 reviewed alcohol's effects on AF and concluded that its consumption was a risk factor for AF, causing increased recurrence and higher rates of paroxysmal and persistent AF. They further commented that the cardioprotective benefits of alcohol on IHD do not apply to AF. In a UK cohort (N=703 777), moderate-to-high consumption of alcohol was identified as an independent risk factor for progression of paroxysmal AF to persistent AF (odds ratio, 2.7; 95% CI, 1.2-6.0). 58 In 115 patients with a recorded idiopathic AF episode, patients who experienced recurrence (n=32) had a significantly higher incidence of consuming alcohol regularly (P=0.014). 59 Alcohol's effects on cardiac conduction have also been investigated. In a pilot study of 14 patients with a reported heart disease, acute excessive alcohol intake slowed intra-atrial conduction and shortened ventricular myocardial refractory periods. 60 As for interatrial conduction, which is usually measured by the P-wave duration and has been found to be a predictor of AF; 61 a study showed that average P-wave duration was significantly affected after alcohol intake in normal healthy subjects (107±9 versus 125±11; P<0.05). 62 However, the duration was more altered after alcohol consumption for patients with a documented history of paroxysmal AF than in control subjects (125±11 versus 158±29; P<0.05).
THE FRENCH PARADOX AND BEYOND
Renaud and de Lorgeril 8 first coined the term French Paradox in 1992, an observation of low IHD and associated mortality despite the high intake of saturated fat in southern France. The authors attributed the cardioprotective effects of this phenomenon to the moderate consumption of alcoholic beverages, especially red wine, which was highly consumed in the area. Although Renaud and de Lorgeril strengthened their association between wine consumption and IHD by controlling for dairy fat intake, 63 other authors have argued that there were characteristics and confounding variables not controlled for in their analysis (drinking patterns, lifestyle characteristics, dietary intake, human behavior) which may have led to such a correlation.
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Role of Wine Versus Other Alcoholic Beverages on IHD and Total Mortality
A J-or U-shaped relationship between alcohol consumption and total mortality has been well documented, 65 with the first incidence being reported as a U-shaped curve between IHD mortality for heavy male smokers and nonsmokers in the Framingham Heart Study. 66 Since then, several investigators have focused on exploring the effects of specific alcoholic beverages on IHD. An L-shaped relation between cardiovascular mortality and alcohol intake has been shown, 67 implying that a low dose of alcohol intake can have protective effects that do not decrease with elevated intakes. Many studies have reported inverse associations between specific types of alcoholic drinks and IHD. No consistent pattern of a specific type of alcoholic drink (wine, beer, or spirits) reducing the risk of IHD has been confirmed, rather a strong epidemiological accord that all alcoholic drinks are linked with a reduction in risk from IHD, if not consumed in excessive amounts, or binged on. Rimm and colleagues 64 conducted a systematic review assessing the risk of specific alcoholic drinks on IHD. Focusing on ecological, case-controlled, and cohort studies, they identified 4 investigations that reported an inverse association between wine intake and IHD and mortality, [68] [69] [70] [71] 4 that correlated beer intake and coronary events, 68,72-74 and 3 with an emphasis on a correlation for spirits.
2,74,75 A summary of selected major clinical studies reporting the associations between IHD and alcohol consumption, including wine, is presented in Table 4 . The 3 largest prospective studies mentioned 2, 69, 71 where the absolute consumption of wine, beer, and spirits would be the greatest, found that the risk of IHD was lower with all 3 types of drinks, with no particular drink emerging as a clear winner. 64 A prospective observational study by Klatsky and Armstrong 71 found that individuals who preferred wine were at a lower risk of death from IHD, after comparisons with spirits drinkers as a reference group (RR, 0.7; 95% CI, 0.5-0.9). To support their findings, this group reported an inverse association between IHD risk and frequency of wine consumption, but they were not able to confidently conclude that wine confers a greater protective advantage because of user differences and the inability to control for all potentially confounding variables. A Danish cohort study 68 assessing the population for all 3 types of alcoholic drinks in a homogeneous setting, where not 1 alcoholic drink predominated, found a significant decrease in mortality, from IHD and all causes, among wine drinkers, at all levels of alcoholic intake. Conversely, light alcohol drinkers who avoided wine had a relatively higher risk of death from IHD than drinkers who consumed wine (RR, 0.76; CI, 0.63-0.92 versus RR, 0.58; CI, 0.47-0.72). Additional evidence of the cardioprotective effects of wine from IHD is provided by the results of the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial, 70 which found that moderate wine consumption (≤0.5 L/d) was associated with a significant reduction in the risk of cardiovascular events.
Examining the association between beer and IHD, the Honolulu Heart Study, a prospective epidemiological investigation, 72 found a significant negative correlation between moderate alcohol consumption of beer and death from IHD during a 6-year follow-up period. Such association for wine was not found, but beer was the predominantly consumed drink in the population.
Further support for beer is provided by the MONICA (Monitoring Trends and Determinants of Cardiovascular Diseases) Augsburg cohort study, 67 in which a protective effect from light-to-moderate drinking of alcohol was observed in a predominantly beer-drinking population. Risk reduction from IHD was close to 50%, and the L-shaped relationship was also confirmed. 67 For spirits, Salonen et al 75 reported that consumption at least once a week was associated with a reduced risk of acute myocardial infarction among IHD-free men aged 30 to 59 (RR, 0.5; 95% CI, 0.3-0.9). Furthermore, in a study by Rimm et al, 2 in which spirits were the most commonly consumed drink, found that they were also the most cardioprotective by having a significant inverse association between consumption and risk of IHD (P=0.0004).
The Debate Around Light-to-Moderate Intake of Wine and Other Alcoholic Beverages
Although an inverse relationship between alcohol consumption and risk of IHD has been extensively documented in studies using an epidemiological design, there is a debate regarding which of the 3 drinks provides better cardiovascular benefits, or on a broader scale, if alcohol itself can provide protective benefits. One side of the argument is presented by Rehm et al, 12 who argue that alcohol consumption contributes to Salonen ACI indicates acute coronary insufficiency; CABG, coronary artery bypass graft; CI, confidence interval; HR, hazard ratio; IHD, ischemic heart disease; MI, myocardial infarction; PTCA, percutaneous transluminal coronary angiography; and RR, relative risk. the global chronic disease burden, and further evidence suggests that high doses of alcohol consumption confer a disadvantage to the heart, especially with an increased risk of arrhythmia, sudden cardiac death, alcoholic cardiomyopathy, and hypertension, among others. 76 The other side of the argument is presented in the literature on light-to-moderate alcohol consumption, which is in favor of a reduction in IHD and total mortality. 3 Yano et al 72 were successful in showing a strong negative correlation between moderate alcohol consumption and incidence of IHD for all 3 beverages, supporting the idea of the protective benefit of moderate alcohol consumption. The findings of moderate alcohol consumption were further supported by clinical angiography studies 77 that show a reduction in atherosclerosis and average IHD.
As for wine, Grønbaek 68 showed that, in a Danish cohort, IHD mortality decreased across levels of stable drinking, and that wine (8-21 drinks/wk) conferred a greater protective effect than the intake of light-tomoderate beer or spirits. In Oakland and San Francisco populations, it was shown that light drinkers were at low risk of IHD, with the greatest reduction observed in older populations. 78 The investigators further showed that wine preference and its consumption were associated with a significant reduction in cardiovascular death (RR, 0.7; 95% CI, 0.6-0.9; P=0.01), with no such correlation observed for beer or spirits.
Significant inverse associations were reported for the 3 alcoholic beverages, especially wine, albeit with limitations, because of their epidemiological and clinical study design. There were populations in whom consumption of a single type of drink prevailed over another, and in most cases, that drink conferred the greater effect. Drinking patterns, lifestyle characteristics, dietary intake, and risk factors varied in the populations studied; hence, these could be potential confounding variables for such associations. 64 There are methodological inconsistencies present among all studies, and they make it difficult to draw causal interpretations regarding a specific type of alcoholic drink providing cardioprotective effects, but rather support the finding that alcohol intake of all beverages as a whole is linked with a reduction in risk from IHD, if not consumed excessively or binged on. Considering the aforementioned limitations and methodological inconsistencies present in observational and epidemiological studies, one should be cautious when providing general recommendations to the public. Is it time to change our approach to find the answer? Some have suggested doing prospectively controlled, double-blinded randomized clinical trials, 15 but the ethical dilemma of pursuing such an endeavor still needs to be debated within the scientific community. For now, we shall rely on the evidence at present to make an informed decision.
Acute, Sustained, or No Consumption: Which Is Better?
Most epidemiological and population-based literature surrounding alcoholic beverages considers their sustained consumption to be cardioprotective for IHD-associated mortality. 79 Acute and sustained excessive consumption in the form of binge drinking is associated with arrhythmias (holiday heart syndrome), transient ischemic attack, and sudden cardiac death. 76 Hence, regulation of dosage is a very important consideration among drinkers. Red wine polyphenols in an acute setting postprandial, however, have been shown to exert antioxidant and antiinflammatory effects. Covas et al 25 reviewed randomized controlled human studies on the effects of sustained wine usage on oxidation. They reported contradictory studies 80, 81 for an increase in plasma antioxidant activity after sustained wine consumption in healthy participants. It must be noted that these studies used parallel and crossover study designs with small sample sizes (n=78 and 40, respectively). The participants were also not followed up throughout their lifetimes, all possible reasons for the reported contradiction.
Is one worse off consuming no wine or any alcoholic drink? From a public health perspective, no, because dependence on alcohol only adds to the growing cohort of alcohol use disorders. 13 There are studies, however, that have presented compelling evidence for abstinence from alcohol being a risk factor for myocardial infarction 82 and type 2 diabetes mellitus.
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DEALCOHOLIZED RED WINE: CARDIOPROTECTION OF WINE POLYPHENOLS BEYOND ETHANOL
It is common to dealcoholize wine, and special attention is paid during the manufacturing process to ensure no loss of polyphenols. With such a drink, effects of polyphenols can be studied in isolation. Oxidative modifications in LDL are thought to be an initiator for the development of atherosclerosis, whereas polyphenols are thought to prevent this oxidative stress and enhance plasma antioxidant capability by being present. 84 Inhibition of LDL oxidation is one of the proposed mechanisms by which polyphenols delay the onset of atherosclerosis and reduce cardiovascular risk. Furthermore, red wine and components catechins and anthocyanins inhibited in vitro LDL oxidation, whereas ethanol and dealcoholized red wine did not affect measured oxidation levels. 84 These observations were also present in wine with ethanol; here, we confirm the same results in dealcoholized red wine. To evaluate the effects of wine polyphenols and their antioxidant potential, Serafini et al 85 conducted a human pilot study of patients with IHD and showed that ingestion of dealcoholized red but not white wine at 1-week intervals greatly increased in vitro plasma antioxidant capacity, with this effect being credited to red wine polyphenols, which are found in much greater concentrations in red wine than in white. 85 An investigation by Stein et al 86 reported that ingestion of purple grape juice (devoid of ethanol) was associated with improved endothelial function via a reduction in susceptibility of LDL-cholesterol to oxidation in 15 adults with IHD.
Red wine polyphenols have also been hypothesized to exert positive effects on flow-mediated vasodilation, which is known to be endothelium-dependent. In the Stein et al 86 cohort, grape juice was also associated with improved flow-mediated vasodilation of the brachial artery, which would in turn improve endothelial function. Treatment of human umbilical vein endothelial cells with dealcoholized red wine led to a 3.0-fold increase in NO release, and a 2.0-fold increase in human endothelial NO synthase, an enzyme isoform that synthesizes NO. 87 In addition, dealcoholized red wine polyphenol extract has been found to almost completely reverse the prothrombotic effects of a 2% cholesterol-rich diet by a NO-dependent mechanism. 88 Red wine polyphenols have displayed potent antioxidant properties in vivo for arterial stiffness. Dealcoholized red wine has been acutely demonstrated to reduce arterial stiffness 60 minutes postprandial intake in patients with coronary artery disease, with this reduction attributed to red wine antioxidants.
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ALCOHOL AND CARDIOPROTECTION: IMPLICATIONS FOR CAUSALITY FROM OBSERVATIONAL EVIDENCE
Much of the evidence regarding alcohol consumption and its beneficial effects on the cardiovascular system derives from observational data. Epidemiological studies have been integral to this discussion, with multiple cohorts with cross-cultural and geographical comparisons reaching similar conclusions. That being said, can one infer causality from epidemiological investigations using an observational-based approach, in which subject bias is inherent with self-reported data?
To determine causation, randomized controlled trials have long been considered the gold standard. However, epidemiological, public health, and clinical research are sometimes barred by ethical concerns, where, for instance, an experimental treatment such as alcohol being investigated for a therapeutic cause may leave participants in harm's way. 90 Nonetheless, several methods have been developed to make causal inferences from epidemiological research, starting with the seminal set of criteria proposed by Austin Hill, to distinguish causal and correlational associations. 91 Since then, other methods have been developed. Some common ones used today include instrumental variables regression analysis, difference in differences, and regression discontinuity designs. 90 These methods seek to use a randomized approach, assigning variables to observational data and using mathematical models to associate the effects of a treatment with measured health outcomes. Evaluating for causal inferences in epidemiology is a growing interest, and it is worthwhile to stress that, in cases where longitudinal epidemiological evidence overwhelmingly points in one direction, when a large number of studies are arriving at similar conclusions, when many proposed mechanisms of action are biologically sound and understandable, and when the aforementioned statistical approaches also associate the treatment positively to the health outcome, one can begin to suggest causal links.
Decades of longitudinal data have shown an improvement in cardiovascular risk factors with low-to-moderate alcohol and wine consumption. Very recently, studies based on Mendelian randomization approaches, an instrumental variables analysis using genetic variants as instruments for analysis, have questioned the cardiovascular benefits of alcohol consumption. 92 In the context of alcohol, Mendelian randomization studies seek to provide evidence of causal relationships and provide a magnitude of the risk associated with lifelong alcohol use by comparing genotypes of interest. 92 Two large European studies (N=261 991; 54 604) using a Mendelian randomization approach to explore causal effects of long-term alcohol consumption on IHD and cardiovascular risk factors (body mass index, blood pressure, interleukin, and lipid levels) by assessing variants of the alcohol dehydrogenase (ADH1B and ADHIC) gene reported adverse effects of alcohol consumption on the cardiovascular risk profile and an increased risk of IHD. 93, 94 Further evidence by Yun et al 95 reports detrimental effects of alcohol consumption on coronary calcification in the Korean population. These studies stand in contrast to the epidemiological investigations.
PUBLIC HEALTH PERSPECTIVES
Because alcohol is a ubiquitous part of culture, its everincreasing consumption today because of industrialization and globalization also increases the adverse effects associated with its intake. 13 Alcohol consumption in excessive amounts can lead to social and personal ramifications not only for individuals, but also for the population as a whole. 96 Intoxication still remains a major factor in adverse events such as car crashes and domestic violence, both of which are major problems for public health. 97, 98 Rehm et al 13 explain how some diseases are causally linked to alcohol and would not exist if alcohol was not a contributor to our day-to-day lives. These include alcoholic liver disease, alcohol use disorder, and pancreatitis induced by alcohol. Further analysis by this group on alcohol-associated detriments finds that in 2004, 3.8% of global mortality was alcohol-associated, greater for men (6.3%) than for women (1.1%). They report the cause of these deaths to be from injury, cancer, liver cirrhosis, and cardiovascular diseases. Surprisingly, the authors find that almost all preventable deaths were from the cardiovascular category. However, this does not take away from the fact that, on average, alcohol is detrimentally linked to many diseases and increases the global disease burden. 13 
RECOMMENDATIONS FOR WINE CONSUMPTION
The most comprehensive manual for healthcare professionals is the WHO guide for hazardous and harmful drinking. 18 It provides healthcare professionals a dayto-day guide on dealing with patients who are more inclined to abuse alcohol. Important sections include concepts and terms related to the use and abuse of alcohol, intervention guidelines, 4 zones of risk management, definition of a standard drink, and guidelines for low-risk alcohol consumption. The 2015 to 2020 Dietary Guidelines for Americans 10 recommend a moderate consumption of alcohol (≤2 std/d men; ≤1 std/d women; 1 standard drink=14 g of pure ethanol). Excessive consumption (≥5 std/d men; ≥4 std/d women) and binge drinking (≥5 std/d men; ≥4 std/d women within 2 hours) are discouraged. High-risk individuals (alcoholics, pregnant or breastfeeding women, individuals on prescribed medications) are advised not to consume alcohol. The American Heart Association advisories 99, 100 conclude that a moderate intake of alcohol (1-2 drinks/d) is associated with a reduction in IHD risk with no clear consensus of wine conferring greater benefits than alcoholic beverages. For women, however, suggested consumption was of no more than 1 drink/d. 99 To substantially reduce cardiovascular disease risk, their recommendation is to focus on a consumption of a healthy diet.
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Conclusions
Despite a lack of consensus on a specific type of beverage being beneficial to the heart, mounting evidence suggests that ethanol and polyphenols within wine can synergistically confer benefits against chronic cardiovascular diseases, mostly IHD. The polyphenols in red wine can be divided into 2 important groups, flavonoids and nonflavonoids, that together can decrease platelet aggregation, improve fibrinolysis, increase HDL cholesterol, and promote NO release.
Discrepancies remain for the definition of a standard drink, with the WHO definition of 10 g not adopted internationally. A light-to-moderate intake is considered cardioprotective by epidemiological and experimental investigations after observations of an inverse correlation for IHD.
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